Mr. Hudson introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
To require the Secretary of Health and Human Services to establish a demonstration project to increase access to biosimilar biological products under the Medicare program.
Citations are generated automatically from bibliographic data
as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. Increasing Access to Biosimilars Act of 2023. H.R. 1352. 118th
Cong., 1st
sess., Introduced in House March 3, 2023. https://www.govinfo.gov/app/details/BILLS-118hr1352ih.
APA
Congress, House of Representatives (2023, March 3). Increasing Access to Biosimilars Act of 2023 (H.R. 1352 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-118hr1352ih.
MLA
United States, Congress, House of Representatives. Increasing Access to Biosimilars Act of 2023. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-118hr1352ih. 118th Congress, H.R. 1352, Introduced in House 3 Mar. 2023.
Bluebook
H.R.1352 - 118th Congress (2023-2024): Increasing Access to Biosimilars Act of 2023, H.R.1352, 118th Cong. (2023), https://www.govinfo.gov/app/details/BILLS-118hr1352ih.
